CJChunlin Jin

Chunlin Jin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Chunlin Jin has a total of 132 co-authors. Here are the top co-authors by number of shared publications:

  • Fen Li

    Financial Management Affairs Center of Shanghai Municipal Health Commission, Shanghai, China

    8 shared publications
  • Bifan Zhu

    Shanghai Health Development Research Center (Shanghai Medical Information Center)

    7 shared publications
  • Jiangjiang He

    Shanghai Health Development Research Center (Shanghai Medical Information Research Center), Shanghai, China

    7 shared publications
  • Changying Wang

    Shanghai Health Development Research Center, Shanghai Medical Information Center, Shanghai, People’s Republic of China

    6 shared publications
  • Duo Chen

    Shanghai Health Development Research Center, Shanghai, China

    6 shared publications
  • Peipei Song

    The Institute for Global Health Policy Research, Bureau of International Health Cooperation, National Center for Global Health and Medicine, Tokyo, Japan

    6 shared publications

Latest Publications

  • Open Access

    Influencing factors of hospitalization costs for patients with subsequent osteoporotic hip fractures: multilevel model analysis by fracture episode

    by Jing Yan, Bifan Zhu, Yan Zhang, Xiaoting Yang, Nan Zhang, Bao Liu, Chunlin Jin

    Background: Osteoporotic hip fractures often require immediate inpatient care and impose a substantial financial burden. Previous studies mainly focused on overall costs for patients with refractures, without disaggregating hospitalization costs by episode, leaving the determinants of first- and second-admission costs unclear in this subgroup. This study aimed to examine factors associated with hospitalization costs for each episode and to identify factors characterizing cost differences between the two hip-fracture hospitalizations in patients with subsequent osteoporotic hip fractures. Methods: Data were obtained from the Shanghai Health Statistics Center, covering all medical institutions in Shanghai, China, from January 1, 2013, to December 31, 2022. Multilevel models were used to identify factors related to hospitalization costs for the first and second fractures. Hospitalization variations and cost differences between the two fracture episodes were examined, and multivariable quantile regression was used to explore factors associated with cost differences. Results: Of 43,963 patients hospitalized for their first osteoporotic hip fracture, 1,152 experienced a subsequent hip fracture and required rehospitalization during the study period. At the first fracture, most patients were female (78.73%) and aged ≥80 years (57.47%). Grade-A tertiary hospitals represented 27.59% ( n = 24) and 24.04% ( n = 25) of treating hospitals for the first and second fractures, respectively, but admitted 55.64% ( n = 641) and 51.39% ( n = 592) of patients. For both episodes, fourth-degree surgery had the highest median costs ($9,787.15 and $9,726.55, respectively), whereas unoperated patients had the lowest ($1,147.75 and $1,133.36). Costs rose substantially with longer length of stay (LOS), reaching $11,197.72 and $11,729.95 for stays of ≥31 days. Null multilevel models of hospitalization costs revealed ICCs of 0.333 and 0.338 for the first and second fractures, respectively, both indicating significant hospital-level variance (all P < 0.001). Random-intercept models showed that grade-A tertiary hospitals showed higher adjusted costs than grade-B secondary hospitals for both fractures, and that higher surgery levels and longer LOS were positively associated with costs across both episodes (all P < 0.001). For the second fracture, an interval of 1 to 1.5 years between hospitalizations was associated with significantly lower costs compared with an interval of ≤1 year (exp( β ) = 0.899; 95% CI , 0.824 to 0.980; P < 0.05). Quantile regression showed that a higher hospital level and longer LOS during the second hospitalization were associated with increased relative costs across quantiles (all P < 0.05). Conversely, a higher surgery level in the second hospitalization was associated with reduced relative costs at the 25th and 50th percentiles (all P < 0.05), indicating heterogeneous associations across different quantiles of the cost distribution. Conclusions: Among patients with subsequent osteoporotic hip fractures, grade-A tertiary hospitals were associated with higher adjusted costs than grade-B secondary hospitals for both fracture episodes, and inpatient costs increased progressively with higher surgery levels and longer LOS. Between-episode variations in hospital level, surgery level, and LOS exhibited heterogeneous effects on cost differences across quantiles. These findings highlight the need for episode-specific cost-control strategies that also account for variations between the two hospitalizations.

  • Open Access

    Association between living arrangements and health outcomes among stroke survivors in China

    by Bifan Zhu, Duo Chen, Xiaohui Hou, Kun Fang, Yunwei Zhang, Chunlin Jin, Hansheng Ding

    Stroke is the leading cause of death and a major cause of disability in China, posing significant challenges for post-stroke care and rehabilitation. Understanding how different living arrangements affect the health outcomes of stroke survivors is increasingly important. This study aims to compare different living arrangements-either living at home or in care institutions-and to evaluate their impact on stroke survivors’ health. Based on the cross-sectional survey data from the Long-Term Care Insurance of Shanghai, China from January to June 2023, we identify the key characteristics of stroke survivors living in different locations. Kernel-based propensity score matching is employed to enhance comparability between groups. Health outcomes, including self-reported health status, and post-stroke infections, are compared between the two living locations. Among 54,575 stroke survivors, 47,347 (86.76%) reside at home, 7,228 (13.24%) live in care institutions. Stroke survivors residing in health institutions are generally older and exhibit worse disability status compared to those living at home. The median Barthel Index of the home group is 10 (6–13), and 5 (2–9) in the institution group (P < 0.05). Individuals living at home (odds ratio [95% CI]) report poorer health status (1.349[1.238–1.470]) and higher risks of pulmonary infections (1.319[1.150–1.513]), urinary tract infections (1.745[1.458–2.090]) and pressure sores (2.410[2.027–2.866]). The Barthel Index correlates with improved self-reported health status, and a reduced risk of pulmonary infections and pressure sores. This is the first large-scale study in China to systematically assess the living arrangements of stroke survivors, revealing significant disparities in health outcomes based on living location. The findings underscore potential limitations in both home care and institutionalized care for stroke survivors and highlight the need for enhanced support in both settings.


  • Open Access

    Hospital-based health technology assessment of central dialysis fluid delivery system for hemodialysis patients

    by Wendi Cheng, Haiyin Wang, Jiangzi Yuan, Ying Li, Yashuang Luo, Yuyan Fu, Leyi Gu, Jun Xue, Chunlin Jin, Yin Zheng

    Background: This study employed a hospital-based health technology assessment (HB-HTA) to evaluate the economic value of the central dialysis fluid delivery system (CDDS) compared to the single-patient dialysis fluid delivery system (SPDDS) in hemodialysis. The findings offer evidence to support hospital procurement and clinical implementation decisions regarding CDDS. Methods: A comparative cost analysis was conducted using micro-costing data collected from three hospitals. Costs were estimated for both CDDS and SPDDS, and economic efficiency was evaluated across multiple hemodialysis machine configuration scales. The analysis included total costs, cost structures, and cost savings, along with their constituent components, to identify scenarios in which CDDS provides economic advantages. Results: In a dialysis center with 6 hemodialysis machines operating two shifts per day and serving 12 patients daily, CDDS reduced costs by 0.05% compared to SPDDS. As the number of machines increased from 6 to 50, the cost reduction rate rose from 0.05% to 21.08%, demonstrating enhanced economic benefits at larger scales. In a 50-machine center, CDDS saved approximately RMB 84 per treatment session and RMB 2,601,108 annually. The majority of cost savings came from reductions in consumables (74%) and labor (24%). One-way sensitivity analysis confirmed that CDDS consistently yielded cost savings, supporting the robustness of the costing model. Conclusion: CDDS demonstrates significant economic value over SPDDS by reducing consumable and labor costs, proving to be a cost-effective solution in dialysis centers with 6 or more machines serving at least 12 patients daily. Clinical engineers play a key role in its implementation. CDDS is suitable for promotion in medium- to large-scale dialysis centers in China.


  • Top Cited Papers

    The global burden of fractures and its underlying etiologies: results from and further analysis of the Global Burden of Disease Study 2021

    by Jing Yan, Fen Li, Jun Zhou, Yuanyuan Ding, Qiujun Qin, Chunlin Jin

    Summary Fractures can result in decreased quality of life and care requirements, all of which significantly affect patients and their families. Our results revealed that the global incident, prevalent, and YLDs cases of fractures have risen in both sexes. Policies that prioritize avoiding fractures at different anatomical sites should be developed. Background Fractures are a major contributor of disease burden and are predicted to rise significantly in the years to come. The purpose of this study was to estimate the global burden of fractures and analyze the changes of etiologies of fractures between 1990 and 2021. Methods Based on the information collected from the Global Burden of Disease (GBD) 2021, this study analyzed both the number and age-standardized rate of incidence, prevalence, and years lived with disability (YLD) of fractures between 1990 and 2021 by sex, age group, anatomical site, GBD region, SDI region, and country. We used estimated annual percentage changes (EAPC) to calculate the trends of the age-standardized rate over the past 30 years. Results In 2021, the number of new cases of fractures was 172.79 million (95%UI 158.38–187.65), with 77.66 million (95%UI 70.53–85.15) cases in females and 95.12 million (95%UI 87.69–102.67) cases in males. The prevalent cases were 453.31 million (95%UI 421.17–486.12) globally. In addition, fractures caused 25.18 million (95%UI 17.28–34.62) YLDs among all ages in 2021, displaying an increasing trend with an EAPC of 1.1. However, there was a general decline in the age-standardized incidence rate (ASIR), age-standardized prevalence rate (ASPR), and age-standardized years lived with disability rate (ASYR) of fractures from 1990 to 2021. The ASIR, ASPR, and ASYR of fracture in 2021 were 2172.52 cases (95%UI 1995.20–2364.46) per 100,000 population, 5397.67 cases 95%UI (5022.63, 5787.16) per 100,000 population, and 300.19 cases (95%UI 205.86–412.53) per 100,000 population. Compared with other countries and territories, New Zealand (6197.81 cases (5391.24–7068.78) per 100,000 population) had the highest ASIR of fractures in 2021, followed by the Republic of Slovenia (5996.53 cases (5367.82–6640.29) per 100,000 population) and Australia 5420.39 cases (4684.64–6301.56) per 100,000 population). Even while we observed that males had more incident, prevalent, and YLDs cases of fractures than females; and higher ASIR, ASPR, and ASYR, it may not apply to fractures at different anatomical sites, such as fracture of hip and fracture of radius and/or ulna. Furthermore, our study revealed that ASIR, ASPR, and ASYR for females were higher than males after the ages of 55–59, 85–89, and 70–74, although the ASPR and ASYR rose with age for both females and males. Falls were the leading ASYR level 3 cause of fractures worldwide, but with a downward trend; road injuries and exposure to mechanical forces were the second and third main causes of fractures. Conclusions Given the rising tendency of incidence, prevalence, and YLDs cases over the past 30 years, bone fractures continue to be a major global burden. In addition, despite the downward trend in ASIR, ASPR, and ASYR of fractures in the high SDI region, it consistently ranked first among the five SDI regions. Increased awareness should be paid to women after the ages of 55 to 59 to lower the incidence rate of fractures. Anti-osteoporotic medication, improving lifestyle habits and multiple-component fall prevention strategies should be considered while making policy.


  • Open Access

    The universal zero markup drug policy and gastric cancer hospitalization expenses: an analysis of trends and influencing factors in Shanghai from 2014 to 2021

    by Yichun Gu, Jiajun Hao, Da He, Hui Sun, Xin Cui, Wenqi Tian, Yulin Zhang, Chunlin Jin, Haiyin Wang

    The increasing hospitalization expenses for Gastric Cancer (GC) impose a notable economic burden on society. Although the Chinese government has implemented the Universal Zero Markup Drug Policy (UZMDP) to control the growth of hospitalization expenditures, costs have continued to rise. Identifying the factors influencing the hospitalization expenses of GC patients is crucial. This study aimed to analyze the trends and factors influencing hospitalization expenses of GC patients in Shanghai from 2014 to 2021. Data were sourced from the Health Network of Shanghai Economic Information Center. We employed interrupted time series analysis (ITSA) to analyze the trends in various medical expenditures before and after the implementation of the UZMDP. The degree of association between various medical expenditures and hospitalization expenditures of GC patients was calculated by using the new grey relational analysis (GRA). Furthermore, multiple linear regression was employed to identify the influencing factors. A total of 23,335 participants were included in this study. The ITSA results showed an increasing trend in hospitalization expenses following the implementation of UZMDP. Drug expenses decreased immediately post-UZMDP, but subsequently began to rise over time. Post-UZMDP, the expenses of medical consumables, examination, and healthcare services all showed an upward trend. The new GRA indicated that the influencing factors of hospitalization expenses, in order of importance, were expenses for drugs, consumables, healthcare services, and examination. Multivariable linear regression analysis revealed that GC patients aged 60 or below incurred lower hospitalization expenses (Coefficient = -780.06, P = 0.0398). However, factors associated with increased hospitalization expenses included longer length of stay (Coefficient = 1753.01, P < 0.001), surgeries (Coefficient = 29,047.26, P < 0.001), and hospitalization in the tertiary hospitals (Coefficient = 25,485.19, P < 0.001) or secondary hospitals (Coefficient = 17,755.12, P < 0.001). Hospitalization expenses of GC patients in Shanghai have been rising annually from 2014 to 2021. Despite the implementation of the UZMDP, drug expenses remain a major factor in escalating hospitalization expenses. The hospitalization expenses of GC patients are significantly influenced by several factors, including the demographic characteristics of patients, the severity of diseases, and the levels of hospitals. These findings provide a basis for more effective management of the hospitalization expenses for GC patients.


  • Open Access

    Analysing the effects of National Centralised Drug Procurement and Price Negotiation Policies on novel hypoglycaemic drug usage and costs in Shanghai, China: an interrupted time series analysis

    by Jie Song, Wei Guo, Chunlin Jin, Yuan Xu, Xiaojing Hu, Zheng Zhang, Hai Lin

    Objectives To analyse the impacts of multiple rounds of National Centralised Drug Procurement Policy (NCDP) and National Drug Price Negotiation Policy (NDPN) on the utilisation, expenditure and daily cost of novel hypoglycaemic drugs. Design The drug procurement data were obtained from the Shanghai Medical Procurement Agency between January 2016 and December 2022. We examined changes in volume, expenditure of overall hypoglycaemic drugs by descriptive analysis. For novel hypoglycaemic drugs, we employed interrupted time series analysis with segmented regression to investigate the change in usage, expenditure and daily cost of specific drug affected by related policies. Setting All the public and private hospitals in Shanghai, China. Primary outcome measures Volume, expenditure and daily cost of novel hypoglycaemic drugs. Results From 2016 to 2022, the overall usage and expenditure of hypoglycaemic drugs in Shanghai have been gradually increasing. Consumption of novel hypoglycaemic drugs had shown a rapid increase, which was significantly increased by 212.28 defined daily doses (95% CI 188.25, 236.31, pConclusion Implementation of NDPN and NCDP had successfully cut-off the price of novel hypoglycaemic drugs and significantly increased their utilisation. In the future, the government needs to control pharmaceutical expenses more strictly while ensuring the rational use of the drugs.


  • Open Access

    Health service utilization, economic burden and quality of life of patients with mucopolysaccharidosis in China

    by Qi Kang, Yuhang Fang, Yan Yang, Dingguo Li, Lin Zheng, Xinyi Chen, Xiaowen Tu, Chunlin Jin

    Background: Patients with mucopolysaccharidosis (MPS) often face delayed diagnoses, limited treatment options and high healthcare costs, that may significantly affect patients' quality of life. The objective of this study was to understand medical service utilization related to diagnosis and treatment, economic burden during diagnosis period, and health-related quality of life among MPS patients in China.Methods: A series of patients diagnosed with MPS registered in the national patient organization were recruited for a cross-sectional survey from May to July 2019. Information were collected from patients or their parents via phone interview, including demographic data, utilization of services related to diagnosis and treatment, total cost during the period of MPS diagnosis and health-related quality of life (HRQoL). HRQoL was assessed by PedsQL 4.0 Generic Core Scale (PedsQL) and 36-item short-form health survey (SF-36) depending on the age of patients with MPS and compared with the general Chinese population.Results: A total of 180 MPS patients (50, 67, 15, 46, 1 and 1 for type I, II, III, IV, VI and VII), with a mean age of 9.54 years and 137 (76.11%) males, were included in analysis. The mean age at first visit to a medical doctor for MPS related symptoms was 3.65 ± 2.58 years old, while only 12 patients (6.67%) were diagnosed on their first visit. The mean diagnostic delay, which is defined as the time between the first visit to a medical doctor for MPS related symptoms and the final diagnosis, was 9.42 months, with no significant difference between types. The average number of misdiagnosis was 4.56. Before the confirmed diagnosis, the patients made an average of 6.31 visits and visited 4.3 hospitals. During diagnosis period, the mean of ¥81,086.72 direct medical costs accounted for 63.75% of the total cost. Only 32.78% of the patients had ever received specific treatments. The mean scores of PedsQL and SF-36 of patients were significantly lower than the Chinese norms. Household annual income per person, specific treatment use and MPS subtype were significantly associated HRQoL of patients.Conclusion: The results highlight challenges faced by MPS patients in terms of diagnosis, access to specific treatments, economic burden and low HRQoL. There is an urgent need to improve early detection and diagnosis, create fair and consistent mechanisms to increase access to specialized treatment and reduce the economic burden of MPS patients in China.


  • Open Access

    Development and initial validation of the career resilience instrument for CDC emergency responders in China within the context of public health emergencies: based on a survey conducted in Shanghai

    by An-Qi Wang, Wen-Di Cheng, Yu-Yan Fu, Ya-Shuang Luo, Juan Li, Hai-Yin Wang, Chun-Lin Jin

    Background: China faces various public health emergencies, and emergency responders at the Centers for Disease Control and Prevention (CDC emergency responders) are a mainstay in responding to public health emergencies. Career resilience can help CDC emergency responders to effectively respond to and recover from public health emergencies, but there is no specific measurement instrument available. In this study, we aimed to develop and conduct an initial validation of the career resilience instrument for CDC emergency responders in China within the context of public health emergencies from a process perspective.Methods: Based on a survey conducted in Shanghai, interpretive phenomenological analysis (IPA), which is a qualitative research approach to describing and analyzing individual experiences, was used to analyze the interview texts to develop the initial career resilience instrument for CDC emergency responders. The initial career resilience instrument was revised through two rounds of expert consultation. Cronbach’s α coefficient and exploratory factor analysis were used to test the reliability and validity of the revised career resilience instrument.Results: The initial career resilience instrument for CDC emergency responders contained three first-level measurement dimensions, 9 second-level measurement dimensions, and 52 measurement items. After expert consultation, the first-level and second-level measurement dimensions were not revised, 13 measurement items were deleted or revised, and six measurement items were added, resulting in 48 measurement items. The revised career resilience instrument was tested for good reliability and validity.Conclusion: Career resilience for CDC emergency responders can be regarded as a set of protective factors and dynamic processes that can be cultivated and intervened in cognitive, affective, and behavioral dimensions to improve their ability to respond to and recover from public health emergencies.